Following an acute ischemic heart event, serum levels of CK-MB and cTnT will not increase immediately [37,38,39]; hence, there is a potential to discover acute myocardial ischemia by measuring the loss of biomarkers in myocardial homogenates. This evidence concerns the gene TNNT2 and myocardial ischemia.